Literature DB >> 17331764

Opioid titration in cancer pain: a critical review.

Sebastiano Mercadante1.   

Abstract

Initiation of therapy with strong opioids is a challenging phase to obtain the maximum benefit and to gain the patient's compliance. The approach could be different, depending on the clinical situation and type of opioid regimen. Substantially, the need to titrate the dose of strong opioids emerges in different conditions: (a) in opioid-naive patients who require an opioid treatment; (b) in patients no longer responsive to weaker drugs requiring strong opioids; (c) in patients already receiving strong opioids requiring higher doses because of an increase in pain intensity or a new acute pain problem; (d) in patients who are severely suffering and need an intensive as well as rapid intervention, due to previous persistent undertreatment. Whilst there is a vast literature confirming the effectiveness of most opioid drugs for the treatment of chronic pain, there is a lack of information regarding opioid titration. This review assesses the principal titration methods and outcomes regarding the different opioid drugs and their modalities of administration, in different clinical contexts.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17331764     DOI: 10.1016/j.ejpain.2007.01.003

Source DB:  PubMed          Journal:  Eur J Pain        ISSN: 1090-3801            Impact factor:   3.931


  17 in total

1.  Clarifications on oxycodone-naloxone combination in cancer pain management.

Authors:  Sebastiano Mercadante
Journal:  Support Care Cancer       Date:  2012-04-14       Impact factor: 3.603

Review 2.  The McGill Pain Questionnaire as a multidimensional measure in people with cancer: an integrative review.

Authors:  Srisuda Ngamkham; Catherine Vincent; Lorna Finnegan; Janean E Holden; Zaijie Jim Wang; Diana J Wilkie
Journal:  Pain Manag Nurs       Date:  2011-05-20       Impact factor: 1.929

Review 3.  Management of cancer pain.

Authors:  Sebastiano Mercadante
Journal:  Intern Emerg Med       Date:  2010-10       Impact factor: 3.397

Review 4.  Pharmacological options for the management of refractory cancer pain-what is the evidence?

Authors:  B Afsharimani; K Kindl; P Good; J Hardy
Journal:  Support Care Cancer       Date:  2015-03-07       Impact factor: 3.603

Review 5.  Pharmacoeconomic impact of adverse events of long-term opioid treatment for the management of persistent pain.

Authors:  Lieven Annemans
Journal:  Clin Drug Investig       Date:  2011       Impact factor: 2.859

Review 6.  Cancer Pain Treatment Strategies in Patients with Cancer.

Authors:  Sebastiano Mercadante
Journal:  Drugs       Date:  2022-09-21       Impact factor: 11.431

Review 7.  Pain treatment with opioids : achieving the minimal effective and the minimal interacting dose.

Authors:  Pierangelo Geppetti; Silvia Benemei
Journal:  Clin Drug Investig       Date:  2009       Impact factor: 2.859

8.  Standard therapy with opioids in chronic pain management : ORTIBER study.

Authors:  Antonio Gatti; Carlo Reale; Roberto Occhioni; Marta Luzi; Alessandra Canneti; Claudia De Polo; Martina Gubernari; Massimo Mammucari; Alessandro Fabrizio Sabato
Journal:  Clin Drug Investig       Date:  2009       Impact factor: 2.859

9.  Pharmacological Characterization of the Mechanisms Involved in Delayed Calcium Deregulation in SH-SY5Y Cells Challenged with Methadone.

Authors:  Sergio Perez-Alvarez; Maria E Solesio; Maria D Cuenca-Lopez; Raquel M Melero-Fernández de Mera; Carlos Villalobos; Hanna Kmita; Maria F Galindo; Joaquin Jordán
Journal:  Int J Cell Biol       Date:  2012-06-17

10.  Opioid receptor activation triggering downregulation of cAMP improves effectiveness of anti-cancer drugs in treatment of glioblastoma.

Authors:  Claudia Friesen; Inis Hormann; Mareike Roscher; Iduna Fichtner; Andreas Alt; Ralf Hilger; Klaus-Michael Debatin; Erich Miltner
Journal:  Cell Cycle       Date:  2014-03-12       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.